Celeris Therapeutics is pioneering AI-driven drug discovery and molecular simulation, utilizing deep learning to predict compound efficacy, simulate molecular interactions, and optimize lead candidates. The platform's algorithms analyze chemical libraries, support structure-based drug design, and accelerate projects in oncology, neurology, and rare diseases. Celeris Therapeutics partners with pharmaceutical companies, biotech firms, and academic institutions, advancing the science of molecular simulation and drug development. SEO keywords: "Celeris Therapeutics AI drug discovery," "AI molecular simulation platform," "deep learning compound optimization," "AI structure-based drug design," "Celeris Therapeutics innovation."